Back to results
US 11,891,427 B2Granted
Amidated peptides and their deamidated counterparts displayed by non-HLA-a*02 for use in immunotherapy against different types of cancers
AssigneeImmatics Biotechnologies GmbH
InventorsJens Hukelmann, Heiko Schuster, Lena Wullkopf, Christoph Schraeder, Jens Fritsche, Daniel Johannes Kowalewski, Michael Roemer, Oliver Schoor
Life of this patent
Estimating the term…
Abstract
The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.
Claims20
A peptide consisting of the amino acid sequence of IYLDRTLLTTI (SEQ ID NO:
- 56) in the form of a pharmaceutically acceptable salt.
Dependencies are inferred from the claim text.